Sign in

CIK 0001612042 · Large accelerated filer

Ascendis Pharma A/S

Sign in to watch
Ticker
ASND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Denmark
Entity type
other
Phone
45 70 22 22 44
Business address
TUBORG BOULEVARD 12, HELLERUP, Denmark
  1. 6-K Event Report of Foreign Issuer
  2. 6-K Event Report of Foreign Issuer
  3. 6-K Event Report of Foreign Issuer
  4. 6-K Event Report of Foreign Issuer
  5. 6-K Event Report of Foreign Issuer
  6. 6-K Event Report of Foreign Issuer
  7. 6-K Event Report of Foreign Issuer
  8. 6-K Event Report of Foreign Issuer
  9. 6-K Event Report of Foreign Issuer
  10. 6-K Event Report of Foreign Issuer
  11. 6-K Event Report of Foreign Issuer
  12. 4 Open-market buy EVP & Chief Financial Officer bought 100 shares at $219.00 ($21,900)
  13. 4 Open-market buy Director bought 500 shares at an average $223.12 ($111,562)
  14. 4 Open-market buy EVP & Chief Financial Officer bought 250 shares at $223.32 ($55,830)
  15. 3/A Insider 3/A
  16. 4 Open-market buy Director bought 400 shares at an average $237.80 ($95,121)
  17. SD Other Specialized Disclosure
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. 6-K Event Report of Foreign Issuer

Page 2 of 40 · 799 filings